Comparative Analysis of Head and Neck and Non–Head and Neck Malignant Peripheral Nerve Sheath Tumors
- 25 September 2015
- journal article
- research article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 154 (1) , 113-120
Abstract
Objectives: Malignant peripheral nerve sheath tumors (MPNSTs) are a group of tumors that arise from peripheral nerves or from the various elements of the nerve sheath, including Schwann cells and perineural fibroblasts. Head and neck MPNSTs (HN‐MPNSTs) are rare, accounting for 8% to 16% of all soft tissue sarcomas. This study analyzes the demographic, clinicopathologic, and survival characteristics of HN‐MPNSTs and establishes comparisons with MPNSTs at other body sites (other‐MPNSTs).Study Design: Analysis of population‐based tumor registry.Setting: Academic medical center.Subjects and Methods: The SEER database (Surveillance, Epidemiology, and End Results; 1973‐2012) was queried for HN‐MPNSTs (324 cases) and other‐MPNSTs (1680 cases). Data were analyzed comparatively with respect to various demographic and clinicopathologic factors. Disease‐specific survival was analyzed with the Kaplan‐Meier model.Results: Mean age at diagnosis for HN‐MPNST was 49.1 years, compared with 46.1 years for other‐MPNSTs (P =. 0169). There was a sex predilection for males in HN‐MPNSTs (60.2%) versus a female predilection for other‐MPNSTs (54.2%; P <. 0001). Average tumor size for HN‐MPNSTs was 4.9 cm, compared with 8.7 cm for other‐MPNSTs (P <. 0001). HN‐MPNSTs were more commonly of low histologic grade types, whereas other‐MPNSTs were mostly of high histologic grade (P =. 0073). HN‐MPNSTs had a higher 5‐year disease‐specific survival than other‐MPNSTs (65.1% vs 57.4%; P =. 0209).Conclusions: HN‐MPNSTs are rare entities. This study represents the largest series of HN‐MPNSTs to date. Although HN‐MPNSTs and other‐MPNSTs share a common histology, there are important clinical differences between the 2 groups.Keywords
This publication has 24 references indexed in Scilit:
- Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1Neuro-Oncology, 2012
- Oncologic Outcomes of Sporadic, Neurofibromatosis-Associated, and Radiation-Induced Malignant Peripheral Nerve Sheath TumorsAnnals of Surgical Oncology, 2012
- Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor OutcomeAnnals of Surgery, 2009
- Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated TumoursSarcoma, 2009
- Malignant peripheral nerve sheath tumors of the head and neck: Management of 10 cases and literature reviewHead & Neck, 2006
- Malignant peripheral nerve sheath tumorsCancer, 2006
- Malignant Peripheral Nerve Sheath Tumors of the Head and Neck: Analysis of Prognostic FactorsOtolaryngology–Head and Neck Surgery, 2000
- Malignant peripheral nerve sheath tumors of the head and neck: A clinicopathological studyJournal of Surgical Oncology, 1994
- Malignant nerve sheath tumors of the head and neck: A combined experience from two university hospitalsThe Laryngoscope, 1991
- A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity.Journal of Medical Genetics, 1989